GenVec, Inc.
GNVC
GNVC was delisted on the 15th of June, 2017.
0 hedge funds and large institutions have $0 invested in GenVec, Inc. in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 15 closing their positions.
100% less funds holding
Funds holding: 15 → 0 (-15)
100% less capital invested
Capital invested by funds: $842K → $0 (-$842K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$494K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$156K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$104K |
| 4 |
Renaissance Technologies
New York
|
-$62K |
| 5 |
Morgan Stanley
New York
|
-$12K |
GNVC Hedge Fund Activity: Q2 2017 in Review
0 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in GenVec, Inc. (GNVC) for Q2 2017, worth a combined $0 — down 100% from $842K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of GNVC and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $494K sold.
- 0 institutional investors held GenVec, Inc. (GNVC) as of Q2 2017, down from 15 in Q1 2017.
- Funds reported $0 of GenVec, Inc. stock for Q2 2017, down 100% quarter-over-quarter.
- 0 funds opened new GenVec, Inc. positions in Q2 2017 and 15 closed out, a net change of -15 holders.
- The largest GenVec, Inc. seller in Q2 2017 was BlackRock, an estimated $494K sold.
Based on aggregated 13F filings for Q2 2017.